First Trust Nasdaq Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since May 21, 2026 Loss -0.02%

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF price gained 1.69% on the last trading day (Wednesday, 3rd Jun 2026), rising from $33.95 to $34.53. During the last trading day the ETF fluctuated 1.89% from a day low at $33.91 to a day high of $34.55. The price has risen in 6 of the last 10 days and is up by 1.86% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 10 thousand more shares were traded than the day before. In total, 12 thousand shares were bought and sold for approximately $428.18 thousand.

The ETF is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect FIRST TRUST NASDAQ PHARMACEUTICALS ETF with a 90% probability to be traded between $33.89 and $35.73 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and ETFS seldom manage to go directly from the bottom of a trend up to the top. ETFS turning up in the middle of a horizontal trend are therefore considered to be potential runners.

FTXH Signals & Forecast

Mostly positive signals in the chart today. The FIRST TRUST NASDAQ PHARMACEUTICALS ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $34.66. On a fall, the ETF will find some support from the long-term average at approximately $34.22. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 1.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). FIRST TRUST NASDAQ PHARMACEUTICALS has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. The ETF had a Golden Star Signal on Wednesday, May 20, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for FIRST TRUST NASDAQ PHARMACEUTICALS ETF

FIRST TRUST NASDAQ PHARMACEUTICALS finds support from accumulated volume at $34.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $0.640 between high and low, or 1.89%. For the last week the ETF has had daily average volatility of 0.95%.

Our recommended stop-loss: $32.67 (-5.38%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (FTXH) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect FIRST TRUST NASDAQ PHARMACEUTICALS ETF to open at $34.33, and during the day (based on 14 day Average True Range), to move between $34.31 and $34.74, which gives a possible trading interval of +/-$0.433 (+/-1.26%) up or down from last closing price. If FIRST TRUST NASDAQ PHARMACEUTICALS ETF takes out the full calculated possible swing range there will be an estimated 1.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $34.53 (0.02%) than the support at $34.14 (1.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for FIRST TRUST NASDAQ PHARMACEUTICALS ETF to perform well in the short-term period. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Hold to a Buy candidate.

Current score: 3.567 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $34.33 ( 0.575%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk